When it comes to genomic technology, Carol Isaacson Barash is a go-to source. She is the founder of Helix Health Advisors, a consultancy specializing in integrating transformative genomic technologies at the point of care. She also has 25 years of experience in genetics/genomics technologies, bioethics and applications to clinical care.
Barash will be speaking at 9:20 a.m. on the second day of MedCity CONVERGE. The third annual CONVERGE will take place July 15-16 in Philadelphia.
Payers, providers, medtech, pharma, digital health, startups and investors will all come together at CONVERGE to focus on healthcare’s greatest opportunities and challenges. Check out the agenda and register today.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
To give readers a better sense of the speakers in the run-up to the conference, we asked them some questions.
What or who inspires your work in healthcare?
Convergence of emerging technologies – IT/digital/genetics.
Where are patients in the evolution to personalized medicine – watching from the sidelines, waiting at the starting line, joining the race? What’s the profile of an early adopter?
Increasingly at the center and driving research — particularly in oncology.
Will personalized medicine have a particularly strong impact on a certain condition or patient population first?
It already is in cancer discovery and treatment.
Find Barash on Twitter (@carolisaacsonbarash) and LinkedIn.